Corcept Therapeutics (CORT) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $118.10 +0.79%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $105.7 million versus the consensus estimate of $104.91 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Halozyme adds biotech executive Appelhans to its board
- EXL closes $1 billion credit facility, up from $600 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
